Glatiramer Subcutaneous and Zanamivir Inhalation, oral/nebulization
Determining the interaction of Glatiramer Subcutaneous and Zanamivir Inhalation, oral/nebulization and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: glatiramer
Brand name: Copaxone, Glatopa
Synonyms: Glatiramer (injection), Glatiramer Acetate
Generic Name: zanamivir
Brand name: Relenza
Synonyms: Zanamivir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Glatiramer Subcutaneous-Zanosar
- Glatiramer Subcutaneous-Zantac
- Glatiramer Subcutaneous-Zantac (Ranitidine Injection)
- Glatiramer Subcutaneous-Zantac (Ranitidine Syrup)
- Glatiramer Subcutaneous-Zantac (Ranitidine Tablets and Capsules)
- Glatiramer Subcutaneous-Zantac Cool Mint
- Zanamivir Inhalation, oral/nebulization-Glatopa
- Zanamivir Inhalation, oral/nebulization-Glatopa injection
- Zanamivir Inhalation, oral/nebulization-Glecaprevir and pibrentasvir
- Zanamivir Inhalation, oral/nebulization-Gleevec
- Zanamivir Inhalation, oral/nebulization-Glenmax PEB DM
- Zanamivir Inhalation, oral/nebulization-Glenmax PEB DM FORTE